CI
RPRX icon

Capital International’s Royalty Pharma RPRX Stock Holding History

Capital International’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.4M Buy
570,577
+268,954
+89% +$11.8M 1.01% 26
2025
Q4 		$11.7M Buy
301,623
+97,251
+48% +$3.71M 0.41% 64
2025
Q3 		$7.21M Buy
204,372
+4,558
+2% +$165K 0.26% 89
2025
Q2 		$7.2M Buy
+199,814
New +$6.62M 0.28% 88

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Capital International's RPRX Position: Q1 2026 in Review

Capital International increased its Royalty Pharma (RPRX) stake by 89% in Q1 2026, buying an estimated $11.8M and bringing the position to 570,577 shares worth $27.4M. The position accounts for 1.01% of the portfolio, ranked #26.

Capital International first reported a position in RPRX in Q2 2025 and has held it in 4 quarters since. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Capital International held 570,577 shares of Royalty Pharma worth $27.4M as of Q1 2026.
  • Capital International bought 268,954 Royalty Pharma shares in Q1 2026, an estimated $11.8M.
  • Royalty Pharma made up 1.01% of Capital International's portfolio in Q1 2026, its #26 holding.
  • Capital International first reported a position in Royalty Pharma in Q2 2025 and has held it in 4 quarters since.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Capital International's 13F filing for Q1 2026, filed 13 May 2026.